general-medicine
Lower Respiratory Tract Infection (Primary Care)
CRB-65 risk stratification and antibiotic decision for LRTI in primary care
Source: NICE NG138 / NICE antimicrobial guidance
Step 1 of ~7
info
LRTI Assessment
New/changed cough + at least 1 of: fever, purulent sputum, breathlessness, pleuritic pain, wheeze. Exclude pneumonia with clinical assessment ± CXR.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Clarithromycin · Macrolide Antibiotic — Respiratory / H. pylori / MAC
- Flucloxacillin (Burns — Wound Infection) · Antibiotic — Penicillinase-Resistant Penicillin
- Colistin (Polymyxin E — XDR Burns Infection) · Antibiotic — Polymyxin (Last-Resort)
- Doxapram hydrochloride · Respiratory stimulant
- Doxycycline 100mg (Acne / Rosacea) · Oral tetracycline antibiotic (anti-acne / anti-rosacea)
- Lymecycline 408mg (Acne) · Oral tetracycline antibiotic (anti-acne)
Decision support only. Always apply local guidelines and clinical judgement.